Citi Appointed as Depositary Bank for I-Mab’s Sponsored ADR Program

Citi’s Issuer Services, acting through Citibank, N.A., has been appointed as the depositary bank by I-Mab for its American Depositary Receipt (ADR) program. I-Mab is a clinical-stage biopharmaceutical company committed to the discovery, development and commercialization of novel or highly differentiated biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders.

I-Mab’s program was established in connection with a $103,703,600 initial public offering of its ADRs (exclusive of the over-allotment option), priced at $14.00 per ADR. The ADRs are listed on the Nasdaq Global Market under the symbol “IMAB.” Each 10 ADRs represent 23 ordinary shares of I-Mab.

“Citi is proud to be selected as depositary bank for I-Mab’s ADR program,” said Dirk Jones, Head of Global Issuer Services at Citi. “Citi is committed to providing I-Mab and its investors with the highest quality ADR services.”

Citi is a leading provider of depositary receipt services. With depositary receipt programs in 61 markets, spanning equity and fixed-income products, Citi leverages its global network to provide cross-border capital market access to issuers, intermediaries and investors.

For more information about Citi’s Depositary Receipt Services, please visit



Citi, the leading global bank, has approximately 200 million customer accounts and does business in more than 160 countries and jurisdictions. Citi provides consumers, corporations, governments and institutions with a broad range of financial products and services, including consumer banking and credit, corporate and investment banking, securities brokerage, transaction services, and wealth management.

Additional information may be found at | Twitter: @Citi | YouTube: | Blog: | Facebook: | LinkedIn:


Sophia Anthony
Citi Global Public Affairs
Banking, Capital Markets & Advisory Communications
+1 (212) 816-7140

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.